Butyrylcholinesterase (BChE) has been considered as a potential therapeutic target for Alzheimer’s disease (AD) because of its compensation capacity to hydrolyze acetylcholine (ACh) and its close association with Aβ deposit. Here, we identified S06-1011 (hBChE IC50 = 16 nM) and S06-1031 (hBChE IC50 = 25 nM) as highly effective and selective BChE inhibitors, which were proved to be safe and long-acting
丁酰胆碱酯酶(BChE)因其水解乙酰胆碱(ACh)的补偿能力及其与Aβ沉积的密切关系而被认为是阿尔茨海默病(AD)的潜在治疗靶点。在这里,我们确定了S06-1011 ( h BChE IC 50 = 16 nM) 和S06-1031 ( h BChE IC 50 = 25 nM) 为高效、选择性 BChE 抑制剂,并被证明是安全且长效的。候选化合物在东莨菪碱和 Aβ 1-42肽诱导的认知缺陷模型中表现出神经保护作用和改善认知的能力。最佳候选者S06-1011提高了BChE底物ghrelin的水平,可以起到改善精神情绪食欲的作用。 S06-1011处理组的体重增加显着增加。因此,抑制BChE不仅对痴呆具有保护作用,而且对治疗和护理也有很大作用。
ANTHRAQUINONIC DERIVATIVES AND THEIR USE AS COLOURING AGENTS
申请人:PILI
公开号:US20210309860A1
公开(公告)日:2021-10-07
The present invention relates to a compound of formula (I-0) or a salt thereof. The invention further relates to the use of such compound as a colouring agent. The invention also relates to a colouring composition comprising such compound.
Jacobs; Heidelberger, Journal of the American Chemical Society, 1917, vol. 39, p. 1437
作者:Jacobs、Heidelberger
DOI:——
日期:——
[EN] ANTHRAQUINONIC DERIVATIVES AND THEIR USE AS COLOURING AGENTS<br/>[FR] DÉRIVÉS ANTHRAQUINONIQUES ET LEUR UTILISATION EN TANT QU'AGENTS COLORANTS
申请人:PILI
公开号:WO2020016245A1
公开(公告)日:2020-01-23
The present invention relates to a compound of formula (I-0) or a salt thereof. The invention further relates to the use of such compound as a colouring agent. The invention also relates to a colouring composition comprising such compound.